Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01022645 · ClinicalTrials.gov registry record
Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 42
- Enrollment target
NCT01022645: Completed study, sponsored by Northwestern University.
NCT01022645 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01022645 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The study is being done in order to gain information on the most suitable types of birth control in women who recently had gestational diabetes, or diabetes diagnosed during pregnancy. The intrauterine device (IUD) is a highly effective form of birth control. It is inserted into the uterus and prevents pregnancy for either 5 or 10 years, depending on the type of IUD (hormone-releasing or copper). The hormone-releasing IUD works for 5 years and releases a hormone called a progestin into the uterus. The copper IUD contains no hormones and works for 10 years. The IUD is an excellent form of birth control postpartum, but it is unknown if the hormone-releasing IUD will affect blood sugars and increase a woman's risk of becoming diabetic when she's not pregnant. The hypothesis is that the hormone-containing IUD will NOT increase blood sugars, so women who use the hormone-containing IUD will have similar blood sugars to those who use the copper IUD or have had their tubes tied (no hormones).
Interventions
- DEVICE Mirena (Levonorgestrel IUD)
- DEVICE Paragard (Copper IUD ) or Tubal Ligation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-08 |
What the finished NCT01022645 record still lists
NCT01022645 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Mirena (Levonorgestrel IUD) is the first listed.
NCT01022645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01022645 about?
NCT01022645 is a clinical study titled "Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes". The study is being done in order to gain information on the most suitable types of birth control in women who recently had gestational diabetes, or diabetes diagnosed during pregnancy. The intrauterine device (IUD) is a highly effective form of birth control. It is inserted into the uterus and preve...
What is the current status of trial NCT01022645?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2009-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01022645?
The interventions under investigation include: Mirena (Levonorgestrel IUD) (DEVICE), Paragard (Copper IUD ) or Tubal Ligation (DEVICE).
Who is sponsoring clinical trial NCT01022645?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia